New aspects of insulin therapy in type 1 and type 2 diabetes.

被引：2
作者：
Dills D.G. [1 ]
机构：
[1] University of Colorado Department of Medicine, University of Colorado Health Sciences Center, F-732 Anschutz Center for Advanced Medicine, 1635 N. Ursula Street, Aurora, 80010, CO
来源：
Current Diabetes Reports | 2001年 / 1卷 / 2期
关键词：
Hypoglycemia; Human Insulin; Insulin Glargine; Basal Insulin; Intensive Insulin Therapy;
D O I：
10.1007/s11892-001-0022-x
中图分类号：
学科分类号：
摘要：
Tight control of the blood glucose level decreases the frequency of complications of both type 1 and type 2 diabetes mellitus. Until recently, the available short, intermediate, and long-acting forms of insulin could not readily be used to achieve tight glycemic control without introducing an unacceptably high risk of hypoglycemia or demanding an impracticably rigid lifestyle. With the introduction of faster-acting insulin analogues, lispro and aspart, and a peakless long-acting insulin analogue, glargine, the goal of safe and effective tight glycemic control may now be within reach for many patients. The use of these new insulins allows the clinician and patient an expanded range of options for achieving good control of fasting and postprandial blood glucose levels.
引用
收藏
页码：112 / 118
页数：6
相关论文
共 116 条
[1]  
Rizza RA(1993)The effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-978
[2]  
Gerich JF(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 351 837-853
[3]  
Haymond MW(1980)Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional therapy N Engl J Med 303 1313-1318
[4]  
Heinemann L(1992)Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal Horm Metab Res 26 137-139
[5]  
Starke AAR(1983)Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus Diabetes Care 6 374-377
[6]  
Hohmann A(1996)Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patient the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin Diabet Med 13 625-629
[7]  
Berger M(1999)Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: abs kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects Diabetes Care 22 1501-1506
[8]  
Dimitriadis GD(1991) β-chain alter finding to the IGF-receptor with minimal effect on insulin receptor binding [abstract] Diabetes 40 168A-168A
[9]  
Gerich JE(1994)Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM Diabetologia 37 713-720
[10]  
Heinemann L(1997)Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment Diabetes 46 265-270
12345678910